Outpatient Drug‐Induced Parenchymal Liver Disease Requiring Hospitalization
- 12 November 1986
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 26 (8) , 633-637
- https://doi.org/10.1002/j.1552-4604.1986.tb02963.x
Abstract
A case‐history study of drug‐induced liver disorders requiring hospitalization was carried out at the Group Health Cooperative of Puget Sound, a health maintenance organization with about 280,000 members, for the five‐year period from January 1, 1977 to December 31, 1981. During this time, there were 12 instances of hospitalization for liver disorders judged to be probably (nine cases) or possibly (three cases) attributable to outpatient drug ingestion (other than antitumor agents). The rate was on the order of one per 100,000 person‐years at risk. Drugs implicated as probable causes were ampicillin (two cases), carbamazepine (one case), erythromycin (one case), methyldopa (one case), sulfasalazine (one case), quinidine (one case), trimethoprim/sulfamethoxazole (one case), and multiple drugs (one case).This publication has 22 references indexed in Scilit:
- Drug‐Induced Liver DiseaseThe Journal of Clinical Pharmacology, 1981
- Replacement Estrogens and Endometrial CancerNew England Journal of Medicine, 1979
- Methyldopa Liver DamageBMJ, 1974
- Jaundice Associated with AmitriptylineThe British Journal of Psychiatry, 1969
- Carbamazepine-induced jaundice.BMJ, 1967
- CHLORAMPHENICOL AND JAUNDICE IN A BABYThe Lancet, 1967
- Hepatitis with biliverdinaemia in association with indomethacin therapy.BMJ, 1967
- HEPATITIS CAUSED BY THE NEWER AMINE-OXIDASE-INHIBITING DRUGSThe Lancet, 1961
- Hypersensitivity to para-aminosalicylic acidThe American Journal of Medicine, 1960
- Intrahepatic cholestasis following administration of chlorpropamideThe American Journal of Medicine, 1960